SightfileU.S. market data from official filings

FILANA THERAPEUTICS INC (FLNA)

Name: FILANA THERAPEUTICS INC (FLNA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001069530 · EDGAR filings · Updated 2026-06-15

FILANA THERAPEUTICS INC (FLNA) has reported institutional ownership of 28.2%, with 100 institutional managers holding positions valued at $23.1M per the latest 13F reporting period.

Institutional ownership

28.2%

Institutional managers

100

Reported 13F value

$23.1M

Insider activity

9 trans.

$1.23M net buying

Latest updates

2026-06-15 — Current report (8-K) filed
2026-05-07 — Quarterly report (10-Q) filed
2026-05-07 — Current report (8-K) filed
2026-04-28 — ARS filed
2026-04-28 — Proxy statement (DEF 14A) filed
2026-04-28 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, FILANA THERAPEUTICS INC has 100 institutional holders and institutional ownership of 28.2%.

Insider activity

Insiders reported 9 transactions (9 buys, 0 sells) across 3 reporting insiders, with a net reported value of $1.23M.

Related companies

GYRE THERAPEUTICS INC (GYRE) · GENELUX CORPORATION (GNLX) · INOTIV INC (NOTVQ) · NEXTCURE INC (NXTC) · Black Hawk Acquisition Corp (BKHA) · ACRIVON THERAPEUTICS INC (ACRV)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.